Graduate Degree in Biotechnology or any Life Sciences subject from a recognized University or equivalent. Understanding the Molecular Mechanism in Ceramide Induced Pathological Activation of Nek7/Nlrp3-Inflammasome.
Bachelor of Science (B.Sc) with biology as main subject, Bachelors in Engineering with biotechnology (MSc) with minimum 55% of total marks (equivalent grade) in Molecular biology, Genetics, Biochemistry, Biotechnology.
Masters degree in the bioinformatics or relevant disciplines, with demonstrated interest and experience in bioinformatic analysis and a strong computational background.
Gracure Pharmaceutical Ltd. is a Delhi based pharmaceutical company, established in 1992 by Mr. A.S Bhargava with the vision of making world class affordable medicines.
Having good experience and exposure in Dispensing. Granulation, Compression, Coating. Preference to Enteric & Sugar Coating, and Compression Kilian & Fette Machines, Packing CVC Blister Packing & Blister Cartonator.
Apertura Gene Therapy, a biotechnology company focused on innovative gene therapy solutions announced several licensing deals with Galibra Neuroscience and Emugen Therapeutics to utilize Apertura’s human transferrin receptor 1 capsid (TfR1 CapX) for their central nervous system (CNS) programs. A third venture-backed biotechnology company has entered into an Option Agreement with Apertura for multiple CNS indications.
AAVantgarde Bio a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced that the U.S. Food and Drug Administration has granted Fast Track Designation for AAVB-039, the companys gene therapy program for Stargardt disease secondary to biallelic mutation in ABCA4